Aya Ikeda1, Manabu Funayama1, Mari Yoshida2, Yuanzhe Li1, Hiroyo Yoshino1, Tsuyoshi Inoshita1, Kahori Shiba- Fukushima3, Hongrui Meng1, Taku Amo4, Ikuko Aiba5, Yufuko Saito5, Naoki Atsuta6, Ryoichi Nakmura6, Genki Tohnai6, Jun Sone2, Yuko Saito7, Shigeo Murayama7, Yuishin Izumi8, Ryuji Kaji8, Mitsuya Morita9, Akira Taniguchi10, Kenya Nishioka1, Yuzuru Imai1, Gen Sobue11, Nobutaka Hattori1
(1.Department of Neurology, Juntendo University School of Medicine, Japan, 2.Department of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, Nagakute, Japan., 3.Department of drug development for Parkinson's disease, Japan, 4.Department of Applied Chemistry, National Defense Academy, Japan, 5.Department of Neurology, National Hospital Organization Higashinagoya National Hospital, Japan, 6.Department of Neurology, Aichi Medical University, Japan, 7.Department of Neuropathology, Japan, 8.Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Japan, 9.Division of Neurology, Department of Internal Medicine, Jichi Medical University, Japan, 10.Department of Neurology, Mie University Graduate School of Medicine, Japan, 11.Aichi Medical University, Japan)
Abstract password authentication.
You can find the password on page 13 of the program book.